Semiconducting Polymer Dots for Multiplexed Assays

Information

  • Research Project
  • 9141866
  • ApplicationId
    9141866
  • Core Project Number
    R44GM109564
  • Full Project Number
    2R44GM109564-02A1
  • Serial Number
    109564
  • FOA Number
    PA-15-269
  • Sub Project Id
  • Project Start Date
    5/1/2014 - 12 years ago
  • Project End Date
    5/31/2018 - 8 years ago
  • Program Officer Name
    SMITH, WARD
  • Budget Start Date
    6/1/2016 - 10 years ago
  • Budget End Date
    5/31/2017 - 9 years ago
  • Fiscal Year
    2016
  • Support Year
    02
  • Suffix
    A1
  • Award Notice Date
    4/28/2016 - 10 years ago
Organizations

Semiconducting Polymer Dots for Multiplexed Assays

? DESCRIPTION (provided by applicant): Fluorescence based methods play an essential role in modern cell biology and biomedical research. Further development of these techniques has been hindered by the lack of suitable fluorescent probes. To overcome this challenge, various fluorescent nanoparticles have been developed. Among those, semiconducting polymer dots (Pdots) exhibit superior properties such as high brightness, fast emission rate, and excellent photo stability. Fluorescence based techniques encompass a broad area with a large market size, ranging from immuno-assays to super-resolution imaging. And while Pdot has proven to be an excellent general fluorescent probe, to maintain focus, to penetrate the market, and to generate adoption by the biomedical community, we have decided to go after flow cytometry applications, owing to its large market potential. During our 6-month Phase I SBIR project, we have developed Pdot450 and Pdot515 with ultra- high brightness, narrow-band emission, and high photo stability. To achieve this goal of penetrating the flow cytometry market, this Phase II SBIR project proposes to develop 5 additional Pdot probes to complement the 2 developed during Phase I. After this Phase II project, we will have completed a set of 7 Pdots so we may launch a Pdot series with high brightness and narrow emissions for flow cytometry applications. Furthermore, we will establish pre-production and quality control protocols for manufacturing this Pdot series.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    490360
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:490360\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    LAMPROGEN, INC.
  • Organization Department
  • Organization DUNS
    078456317
  • Organization City
    SEATTLE
  • Organization State
    WA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    981156005
  • Organization District
    UNITED STATES